http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103211880-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_229e67329634c01e9d60f2630c64fe15
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2013-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c048eedcfba087376db90c85ab1ab046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8daec46ef7de979d0db5bdcc9fdc237
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9452cb9721c0601df7da183bbda09c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7160c36d7c37eeb7056c2bf56ac42e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5515c772b9ab5122a98dc91d7434c7b
publicationDate 2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103211880-B
titleOfInvention Phyllanthus emblica compound capsule and preparation method thereof
abstract The invention discloses a phyllanthus emblica compound capsule and a preparation method thereof, and belongs to the technical field of medicines. The phyllanthus emblica compound capsule is prepared from a main material and auxiliary materials, wherein the main material is phyllanthus emblica; the auxiliary materials include fruit of purple perilla, semen raphani, semen cassia and hovenia dulcis thumb. The medicines are compounded with one another to promote and improve the effect, so that the defect of a single medicine is overcome. The phyllanthus emblica compound capsule has a good taste, an obvious effect and a long quality guarantee period. The production process of the phyllanthus emblica compound capsule disclosed by the invention is scientific and effective and is simple and easy to operate. Besides, purifying is carried out for the characteristics of different medicine materials, so that the active ingredients are greatly kept and the health requirements of different consumers can be satisfied.
priorityDate 2013-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID296036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419510267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490036
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID48386
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3625
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID99292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280863
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID119260
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID296036
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID119260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407377111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21672667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450961920
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID48386
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID99292
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426385502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281855
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259846

Total number of triples: 38.